AR025724A1 - Tratamiento de estados alergicos e inflamatorios - Google Patents

Tratamiento de estados alergicos e inflamatorios

Info

Publication number
AR025724A1
AR025724A1 ARP000104928A ARP000104928A AR025724A1 AR 025724 A1 AR025724 A1 AR 025724A1 AR P000104928 A ARP000104928 A AR P000104928A AR P000104928 A ARP000104928 A AR P000104928A AR 025724 A1 AR025724 A1 AR 025724A1
Authority
AR
Argentina
Prior art keywords
allergic
person
treatment
workplace
productivity
Prior art date
Application number
ARP000104928A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR025724A1 publication Critical patent/AR025724A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El uso de la desloratadina para la preparacion de un medicamento para hacer que el rendimiento laboral y/o la productividad en el lugar de trabajo de unapersona que sufre de un estado alérgico y/o inflamatorio de la piel o vías respiratorias, poreje mplo, rinitis alérgica estacional, rinitis alérgicapermanente, dermatitis atopica, urticaria o asma alérgico vuelva sustancialmente al rendimiento laboral básico de la persona y a la productividad básica de la.persona en el lugar de trabajo
ARP000104928A 1999-09-22 2000-09-20 Tratamiento de estados alergicos e inflamatorios AR025724A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40059999A 1999-09-22 1999-09-22

Publications (1)

Publication Number Publication Date
AR025724A1 true AR025724A1 (es) 2002-12-11

Family

ID=23584252

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104928A AR025724A1 (es) 1999-09-22 2000-09-20 Tratamiento de estados alergicos e inflamatorios

Country Status (7)

Country Link
EP (1) EP1214071A2 (es)
JP (1) JP2003509459A (es)
AR (1) AR025724A1 (es)
AU (1) AU7589700A (es)
CA (1) CA2383214A1 (es)
PE (1) PE20010752A1 (es)
WO (1) WO2001021162A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003707A1 (en) * 1984-02-15 1985-08-29 Schering Corporation 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
AR008293A1 (es) * 1996-08-16 1999-12-29 Schering Corp Composicion que comprende una cantidad antihistaminica para el tratamiento de las respuestas alergicas de las vias respiratorias superiores
PE71699A1 (es) * 1997-02-07 1999-08-03 Sepracor Inc Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra
US5900421A (en) * 1997-02-11 1999-05-04 Sepracor Inc. Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
CA2288726C (en) * 1997-04-25 2008-04-01 Schering-Plough Kabushiki Kaisha Eyedrops containing a loratadine metabolite

Also Published As

Publication number Publication date
CA2383214A1 (en) 2001-03-29
AU7589700A (en) 2001-04-24
WO2001021162A2 (en) 2001-03-29
WO2001021162A3 (en) 2002-03-07
EP1214071A2 (en) 2002-06-19
JP2003509459A (ja) 2003-03-11
PE20010752A1 (es) 2001-07-17

Similar Documents

Publication Publication Date Title
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
MXPA02000282A (es) Composiciones de cuidado personal.
PE20010710A1 (es) Tratamiento de desordenes del sueno por medio del uso de desloratadina
IL172396A0 (en) Replikin peptides and uses thereof
BRPI0407234A (pt) Heterociclos substituìdos
TR200103233T2 (tr) Antikolinerjik etkili bileşik ve ß-mimetikler bazında yeni ilaç bileşimleri.
EP2335722A3 (en) Use of gelsolin to treat infections
NO20092639L (no) 4-fenyl-6-(2,2,2-trifluor-1-fenyletoksy)pynmidinbaserte forbindelser og anvendelser derav
HK1057330A1 (en) Use of hydroxyethylrutosides for treating symptomsof common cold, allergic rhinitis and infections relating to the respiratory tract
DE602004017588D1 (de) 2-phenoxy- und 2-phenylsulfanyl-benzenesulfonamid derivate mit ccr3 antagonistischer aktivität zur behandlung von asthma und anderen entzündlichen oder immunologischen erkrankungen
ZA200500719B (en) The use of the combination of ciclesonide and antihitamines for the treatment of allergic rhinitis.
PT1392292E (pt) Piranoindazoles e sua utilizacao para o tratamento de glaucoma
ATE445389T1 (de) Liposomale glucocorticoide
BR0315644A (pt) Piperazinil e diazapanil benzamidas e benzotioamidas
IL173188A0 (en) Use of alcohol-oxyalkyates in the form of adjuvants for benzamidoxime gungicidal derivatives, appropriate agents and kits
DE602006020666D1 (de) Methoden und Zusammensetzungen zur Beruhigung von Mund- und Nasenschleimhäuten
TWI347845B (en) Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
AR025724A1 (es) Tratamiento de estados alergicos e inflamatorios
ECSP034872A (es) Nuevos heterociclos 3
BR0313230A (pt) Uso de carboxamidas para o tratamento de tinido
ECSP003664A (es) Tratamiento de estados alergicos e inflamatorios
EE200100527A (et) Osanetandi kasutamine meeleoluhäirete raviks kasulike ravimite valmistamiseks
BR0206918A (pt) Uso de iloperidona
DE60212349D1 (de) Verwendung von n-acetyl-d-glucosamin bei der herstellung eines pharmazeutischen mittels zur prävention und behandlung von sexuellen störungen
BRPI0412288A (pt) uso de aivlosina para o tratamento, prevenção ou controle de doenças em virtude de brachyspira pilosicoli em porcos e ornithobacterium rhinotracheale em aves

Legal Events

Date Code Title Description
FB Suspension of granting procedure